GlaxoSmithKline Consumer Healthcare Ltd Q4 net profit up 8 per cent at Rs 175 cr
New Delhi: GlaxoSmithKline Consumer Healthcare Ltd reported a 8.42 per cent increase in standalone net profit at Rs 175.88 crore for the fourth quarter ended March 31.
The company had posted a net profit of Rs 162.22 crore for the corresponding period a year ago, GSK Consumer Healthcare said in a BSE filing.
Total income from operations for the quarter under review stood at Rs 1,208.76 crore as against Rs 1,192.22 crore during the same period last fiscal, up 13.87 per cent.
For the entire fiscal, the company however reported a decline in net profit at Rs 656.67 crore as against Rs 687.28 crore in 2015-16 fiscal.
Total income from operations for the financial year stood at Rs 4,421.09 crore compared to Rs 4,564.38 crore in the previous year.
GSK said that its board has recommended a dividend of Rs 70 per equity share of Rs 10 each for the 12-month period ended March 31, 2017.
Shares of the company closed 1.93 per cent down at Rs 5,250.80 apiece on BSE.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd